Dopamine agonists, sleep disorders, and driving in Parkinson's disease.
Uitti
Ryan J
RJ
Department of Neurology, Mayo Clinic Jacksonville, Jacksonville, Florida, USA.
Wszolek
Zbigniew K
ZK
D000063:Accidents, Traffic / Q000517:prevention & control; D000978:Antiparkinson Agents / Q000009:adverse effects*; D001921:Brain / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D018491:Dopamine Agonists / Q000009:adverse effects*; D006801:Humans; D009434:Neural Pathways / Q000187:drug effects / Q000473:pathology / Q000503:physiopathology; D010300:Parkinson Disease / Q000188:drug therapy*; D011954:Receptors, Dopamine / Q000187:drug effects / Q000378:metabolism; D012892:Sleep Deprivation / Q000139:chemically induced / Q000503:physiopathology; D012893:Sleep Wake Disorders / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology
D000978:Antiparkinson Agents; D018491:Dopamine Agonists; D011954:Receptors, Dopamine